Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities, 891-892 [2015-00032]

Download as PDF Federal Register / Vol. 80, No. 4 / Wednesday, January 7, 2015 / Notices fcc504@fcc.gov or by calling the Consumer & Governmental Affairs at (202) 418–0432 (TTY). Such requests should include a detailed description of the accommodation requested. In addition, please include a way the FCC may contact you if it needs more information. Please allow at least five days’ advance notice; last minute requests will be accepted, but may be impossible to fill. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. 2015–00004 Filed 1–6–15; 8:45 am] BILLING CODE 6712–01–P FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION [BAC 6735–01] Sunshine Act Notice Sarah L. Stewart, Deputy General Counsel. January 5, 2015. 11:00 a.m., Thursday, January 15, 2015. PLACE: The Richard V. Backley Hearing Room, Room 511N, 1331 Pennsylvania Avenue NW., Washington, DC 20004 (enter from F Street entrance). STATUS: Open. MATTERS TO BE CONSIDERED: The Commission will hear oral argument in the matter Secretary of Labor v. Jim Walter Resources, Inc., Docket No. SE 2012–681–R (Issues include whether the Administrative Law Judge erred in upholding an imminent danger order.) Any person attending this oral argument who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and 2706.160(d). CONTACT PERSON FOR MORE INFO: Emogene Johnson (202) 434–9935/(202) 708–9300 for TDD Relay/1–800–877– 8339 for toll free. TIME AND DATE: Sarah L. Stewart, Deputy General Counsel. [FR Doc. 2015–00086 Filed 1–5–15; 4:15 pm] rljohnson on DSK3VPTVN1PROD with NOTICES BILLING CODE P FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION [BAC 6735–01] Sunshine Act Notice January 5, 2015. 10:00 a.m., Thursday, January 15, 2015. TIME AND DATE: VerDate Sep<11>2014 15:01 Jan 06, 2015 The Richard V. Backley Hearing Room, Room 511N, 1331 Pennsylvania Avenue NW., Washington, DC 20004 (enter from F Street entrance). STATUS: Open. MATTERS TO BE CONSIDERED: The Commission will hear oral argument in the matter Secretary of Labor v. Jim Walter Resources, Inc., Docket No. SE 2011–407–R (Issues include whether the Administrative Law Judge erred in upholding an imminent danger order.) Any person attending this oral argument who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and 2706.160(d). CONTACT PERSON FOR MORE INFO: Emogene Johnson (202) 434–9935/(202) 708–9300 for TDD Relay/1–800–877– 8339 for toll free. PLACE: Jkt 235001 [FR Doc. 2015–00084 Filed 1–5–15; 4:15 pm] BILLING CODE 6735–01–P FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 891 must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than February 2, 2015. A. Federal Reserve Bank of St. Louis (Yvonne Sparks, Community Development Officer) P.O. Box 442, St. Louis, Missouri 63166–2034: 1. First Horizon National Corporation, Memphis, Tennessee; to merge with TrustAtlantic Financial Corporation, and thereby indirectly acquire TrustAtlantic Bank, both in Raleigh, North Carolina. Board of Governors of the Federal Reserve System, January 2, 2015. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2015–00033 Filed 1–6–15; 8:45 am] BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than January 22, 2015. A. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director, Applications and Enforcement) 101 Market Street, San Francisco, California 94105–1579: 1. CITIC Group Corporation, Beijing, China; to retain CLSA Americas, LLC, New York, New York, and to continue to engage in certain permissible nonbanking activities. E:\FR\FM\07JAN1.SGM 07JAN1 892 Federal Register / Vol. 80, No. 4 / Wednesday, January 7, 2015 / Notices Board of Governors of the Federal Reserve System, January 2, 2015. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2015–00032 Filed 1–6–15; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2005–N–0453, FDA– 2003–N–0196, and FDA–2006–O–0314] Sunscreen Feedback Letters; Notice of Availability Under the Sunscreen Innovation Act AGENCY: Food and Drug Administration, HHS. ACTION: Notice; request for comments. The Food and Drug Administration (FDA or Agency) is announcing the availability of letters containing FDA’s initial determinations and feedback on safety and effectiveness data submitted to demonstrate that certain active ingredients are generally recognized as safe and effective (GRASE) and not misbranded for use in over-the-counter (OTC) sunscreen drug products (sunscreen feedback letters). We are taking this action under the Sunscreen Innovation Act (SIA). DATES: Submit either electronic or written comments by February 23, 2015. Sponsors may submit written requests for a meeting with FDA to discuss these proposed sunscreen orders by February 6, 2015. ADDRESSES: Submit electronic comments to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should clearly identify the SUMMARY: specific active ingredient(s) and docket number(s) to which the comments apply. FOR FURTHER INFORMATION CONTACT: Kristen Hardin, Division of Nonprescription Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5491, Silver Spring, MD 20993–0002, 240– 402–4246. SUPPLEMENTARY INFORMATION: I. Background FDA is announcing the availability of six sunscreen feedback letters on its Web site that contain the Agency’s tentative determinations and feedback on safety and effectiveness data submitted to demonstrate that certain active ingredients are GRASE and not misbranded for use in OTC sunscreen drug products. We are taking this action under the SIA (Pub. L. 113–195), enacted November 26, 2014. Before the SIA was enacted, these sunscreen feedback letters were issued to persons seeking OTC monograph status for nonprescription sunscreen active ingredients using the Time and Extent Application (TEA) process under FDA regulations in 21 CFR 330.14, and were also previously made available to the public in the docket. The SIA amended the Federal Food, Drug, and Cosmetic Act (FD&C Act) to, among other things, provide an alternative process for FDA to review the safety and effectiveness of nonprescription sunscreen active ingredients. The SIA establishes new procedures for establishing the conditions under which sunscreens containing active ingredients that have been reviewed through the SIA process and found in a final sunscreen order to be GRASE and not misbranded may be marketed in the United States. Section 586C(b)(3) of the FD&C Act, as added by the SIA, provides that sunscreen feedback letters issued before the SIA was enacted are deemed to be proposed sunscreen orders. Proposed sunscreen orders contain FDA’s tentative determination that a nonprescription sunscreen active ingredient or combination of nonprescription sunscreen active ingredients: (A) Is GRASE and not misbranded if marketed in accordance with such order; (B) is not GRASE and is misbranded; or (C) is not GRASE and is misbranded because the data are insufficient to classify the active ingredient or combination of ingredients as GRASE and not misbranded, and additional data are necessary to allow FDA to determine otherwise. All of the proposed sunscreen orders addressed in this notice have been tentatively classified under category (C), as described in the previous sentence. Accordingly, additional data will be needed to support a determination that any or all of the active ingredients they address are GRASE and not misbranded. II. Sunscreen Feedback Letters Deemed To Be SIA Proposed Orders The six feedback letters that are deemed to be proposed orders under the SIA are identified in Table 1. They can be viewed electronically on FDA’s Web site at https://www.fda.gov/Drugs/ ResourcesForYou/Consumers/ BuyingUsingMedicineSafely/ UnderstandingOver-theCounterMedicines/ucm239463.htm, under the heading ‘‘FDA Regulatory Action on Sunscreen.’’ Related documents, including safety and efficacy data submissions, can be accessed in the corresponding dockets, identified in Table 1, at https:// www.regulations.gov. The letters and associated information may also be viewed by visiting FDA’s Division of Dockets Management (see ADDRESSES). TABLE 1—OTC SUNSCREEN FEEDBACK LETTERS DEEMED TO BE SIA PROPOSED ORDERS Sponsor Bemotrizinol ............................................................ Ciba Specialty Chemicals Corp ............................. 11/13/2014 Bisoctrizole .............................................................. Ciba Specialty Chemicals Corp ............................. 9/3/2014 Drometrizole Trisiloxane ......................................... rljohnson on DSK3VPTVN1PROD with NOTICES Active ingredient L’Oreal USA Products, Inc. .................................... 8/29/2014 Octyl Triazone ......................................................... BASF AG ................................................................ 6/23/2014 Amiloxate ................................................................ Symrise, Inc. .......................................................... Ego Pharmaceuticals Pty. Ltd. ............................... 3V Inc. .................................................................... 2/25/2014 Diethylhexyl Butamido Triazone ............................. 1 Each Date issued 2/21/2014 letter was previously posted in the docket shown in Table 1 on the date that it was issued. VerDate Sep<11>2014 15:01 Jan 06, 2015 Jkt 235001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\07JAN1.SGM 07JAN1 Docket No. 1 FDA–2005–N– 0453 FDA–2005–N– 0453 FDA–2003–N– 0196 FDA–2003–N– 0196 FDA–2003–N– 0196 FDA–2006–O– 0314

Agencies

[Federal Register Volume 80, Number 4 (Wednesday, January 7, 2015)]
[Notices]
[Pages 891-892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00032]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Notice of Proposals To Engage in or To Acquire Companies Engaged 
in Permissible Nonbanking Activities

    The companies listed in this notice have given notice under section 
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and 
Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or 
control voting securities or assets of a company, including the 
companies listed below, that engages either directly or through a 
subsidiary or other company, in a nonbanking activity that is listed in 
Sec.  225.28 of Regulation Y (12 CFR 225.28) or that the Board has 
determined by Order to be closely related to banking and permissible 
for bank holding companies. Unless otherwise noted, these activities 
will be conducted throughout the United States.
    Each notice is available for inspection at the Federal Reserve Bank 
indicated. The notice also will be available for inspection at the 
offices of the Board of Governors. Interested persons may express their 
views in writing on the question whether the proposal complies with the 
standards of section 4 of the BHC Act.
    Unless otherwise noted, comments regarding the applications must be 
received at the Reserve Bank indicated or the offices of the Board of 
Governors not later than January 22, 2015.
    A. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director, 
Applications and Enforcement) 101 Market Street, San Francisco, 
California 94105-1579:
    1. CITIC Group Corporation, Beijing, China; to retain CLSA 
Americas, LLC, New York, New York, and to continue to engage in certain 
permissible nonbanking activities.


[[Page 892]]


    Board of Governors of the Federal Reserve System, January 2, 
2015.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2015-00032 Filed 1-6-15; 8:45 am]
BILLING CODE 6210-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.